| Bioactivity | Botensilimab (AGEN 1181), a humanized anti-cytotoxic T-lymphocyte antigen 4 (CTLA-4) monoclonal antibody, is an innate and adaptive immune activator. Botensilimab can be used for the research of cancer[1]. |
| Invitro | Botensilimab 具有增强的 Fc 区，可增加与抗原呈递细胞和自然杀伤细胞上的 FcγR 的结合[1]。 |
| Name | Botensilimab |
| CAS | 2408310-37-0 |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Delepine C, et, al. 470 Botensilimab, an Fc-enhanced CTLA-4 antibody, enhances innate and adaptive immune activation to promote superior anti-tumor immunity in cold and I-O refractory tumors FREE. |